MassDevice

MassDevice is a news outlet that focuses on the medtech and medical device industry. The publication covers devices that save lives, clinical trials, regulatory processes, research and development, financial updates, legal news and more. MassDevice serves the medtech and medical device industry as well as supplier and contract manufacturers, government organizations/agencies, research hospitals, medical centers and universities. The website is owned by Cleveland-based WTWH Media. The articles provided show a slight favoritism towards Medtronic but still provide balanced information and cite multiple sources.

91%

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

92%

Examples:

  • The articles provided by MassDevice seem to favor Medtronic and its products, but they also provide balanced information and cite multiple sources.

Conflicts of Interest

86%

Examples:

  • MassDevice's Vice President, Mary Ann Cooke, has over 25 years of medical device sales and marketing experience, working for companies such as U.S. Surgical and Abbott Diagnostics.

Contradictions

100%

Examples:

No current examples available.

Deceptions

95%

Examples:

No current examples available.

Recent Articles

  • Medtronic's Game-Changing Inceptiv: The World's First Closed-Loop Spinal Cord Stimulator for Personalized Chronic Pain Relief

    Medtronic's Game-Changing Inceptiv: The World's First Closed-Loop Spinal Cord Stimulator for Personalized Chronic Pain Relief

    Broke On: Friday, 26 April 2024 Medtronic's new Inceptiv closed-loop spinal cord stimulator, the world's smallest and thinnest fully implantable system, offers personalized chronic pain relief through real-time adjustments based on biological signals. The device features a rechargeable lithium battery and MRI access with no restrictions.
  • Recent Studies Highlight Effectiveness and Potential Risks of TAVR in Treating Aortic Stenosis

    Broke On: Sunday, 01 October 2023 Recent studies have shown that Transcatheter Aortic Valve Replacement (TAVR) is effective in treating aortic stenosis in low-risk patients. The PARTNER 3 and Evolut trials found that TAVR outperformed surgical aortic valve replacement (SAVR) in terms of mortality, stroke, and rehospitalization rates at one year. A separate study found that adding left atrial appendage occlusion (LAAO) to TAVR did not increase the risk of complications.